New method for non-invasive prostate cancer screening

September 2, 2014
A team led by researchers at Guangdong Medical College in China has demonstrated the potential of a new, non-invasive method to screen for prostate cancer, a common type of cancer in men worldwide. Credit: S.Li/Guangdong Medical College, China

Cancer screening is a critical approach for preventing cancer deaths because cases caught early are often more treatable. But while there are already existing ways to screen for different types of cancer, there is a great need for even more safe, cheap and effective methods to save even more lives.

Now a team of researchers led by Shaoxin Li at Guangdong Medical College in China has demonstrated the potential of a new, non-invasive method to screen for prostate cancer, a common type of cancer in men worldwide. They describe their laboratory success testing an existing spectroscopy technique called surface-enhanced Raman scattering (SERS) with a new, sophisticated analysis technique called support vector machine (SVM).

As they described in a new paper in Applied Physics Letters, from AIP Publishing, they combined SERS and SVM and applied them to blood samples collected from 68 healthy volunteers and 93 people who were clinically confirmed to have prostate cancer. They found their technique could identify the cases of cancer with an accuracy of 98.1 percent.

If the technique proves safe and effective in clinical trials, it may become a new method available to patients and their doctors, helping to improve the early detection and diagnosis of this type of cancer, said Li.

"The results demonstrate that label-free serum SERS analysis combined with SVM diagnostic algorithm has great potential for non-invasive prostate cancer screening," said Li. "Compared to traditional screening methods, this method has the advantages of being non-invasive, highly sensitive and very simple for ."

A common cause of cancer

According to the World Health Organization, prostate cancer is one of the most common types of cancer in men worldwide and a leading cause of cancer-related death. Every year, there are about 899,000 new cases and 260,000 mortalities, comprising 6 percent of all cancer deaths globally. About 1 in every 6 men will develop prostate cancer over their lifetimes.

While a simple blood test for elevated levels of a protein marker known as (PSA) has been used for years to screen for early cases of prostate cancer, the test is far from perfect because the elevated PSA levels can be caused by many things unrelated to cancer. This contributes to over-diagnosis, uncomfortable tissue biopsies and other unnecessary treatment, which can be costly and carry significant side effects. Because of this, the U.S. Preventative Services Task Force now recommends against PSA-based screening for prostate cancer.

According to Li, many scientists have thought about applying SERS to cancer detection because the surface-sensitive type of spectroscopy has been around for years and is sensitive enough to identify key molecules in very low abundance, like pesticide residues on a contaminated surface. This would seem to make it perfect for spotting subtle signals of DNA, proteins or fatty molecules that would mark a case of cancer—exactly why he and his team tackled the problem.

The challenge, he said, was that these changes were, if anything, too subtle. The signal differences between the serum samples taken from the 68 healthy volunteers and the 93 people with prostate cancer were too tiny to detect. So to accurately distinguish between these samples, Li's group employed a powerful spectral data processing algorithm, support vector machine (SVM), which effectively showed the difference.

While the work is preliminary, it shows that serum SERS spectroscopy combined with SVM diagnostic algorithm has the potential to be a new method for non-invasive screening, Li said. The next research step, he added, is to refine the method and explore whether this method can distinguish cancer staging.

Explore further: New early detection test for prostate cancer: Mi-Prostate Score test improves on PSA for predicting cancer

More information: "Noninvasive prostate cancer screening based on serum surface-enhanced Raman spectroscopy and support vector machine," by Shaoxin Li, Yanjiao Zhang, Junfa Xu, Linfang Li, Qiuyao Zeng, Lin Lin, Zhouyi Guo, Zhiming Liu, Honglian Xiong and Songhao Liu. Applied Physics Letters, September 2, 2014. scitation.aip.org/content/aip/journal/apl/105/9/10.1063/1.4892667

Related Stories

Prostate cancer biomarkers identified in seminal fluid

June 6, 2014

(Medical Xpress)—Improved diagnosis and management of one of the most common cancers in men - prostate cancer - could result from research at the University of Adelaide, which has discovered that seminal fluid (semen) contains ...

Vasectomy may increase risk of aggressive prostate cancer

July 9, 2014

Vasectomy was associated with a small increased risk of prostate cancer, and a stronger risk for advanced or lethal prostate cancer according to a new study from Harvard School of Public Health (HSPH). The researchers found ...

Recommended for you

Counting down to the new ampere

August 29, 2016

After it's all over, your lights will be just as bright, and your refrigerator just as cold. But very soon the ampere—the SI base unit of electrical current—will take on an entirely new identity, and NIST scientists are ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.